practices

Resources News

September 2022

FBMJ Attorneys Baron & McCann Publish Article – Hydrogen Blending: Protecting Against Manufacturer Liability

FBMJ attorneys, Richard Baron and Matthew McCann recently published the article, “Hydrogen Blending: Protecting Against Manufacturer Liability,” in Today’s Boiler, the official magazine of the American Boiler Manufacturers Association. The cover-story article focuses on the time-sensitive topic of hydrogen-blending (HB), a process of blending hydrogen and natural gas with a... READ MORE

September 2022

Joseph McGill Elected Vice President of the State Bar of Michigan

Foley, Baron, Metzger & Juip PLLC is pleased to announce that Joseph McGill, a principal with the firm, was recently elected as the Vice President of the State Bar of Michigan (SBM) for the 2022-2023 bar year. On September 16, 2022, McGill was sworn in by Justice Elizabeth T. Clement... READ MORE

September 2022

FBMJ Welcomes Attorney Suzanne Lewand

Foley, Baron, Metzger & Juip, PLLC is pleased to welcome Suzanne Lewand as a new attorney to the Firm. She joined the firm in August 2022 and will work in the firm’s Medical Malpractice practice group. Randall Juip, Member, made the announcement. Before joining FBMJ, Suzanne worked at two metro-Detroit law... READ MORE

August 2022

FBMJ’s Brian Whitelaw & Anthony Pignotti Obtain No Cause Verdict in Kalamazoo County Case

Foley, Baron, Metzger & Juip attorneys, Brian Whitelaw and Anthony Pignotti, were successful in obtaining a no cause of action verdict in a recent medical malpractice/wrongful death lawsuit in Kalamazoo County. The case involved a claim made against a FBMJ allergy and immunology client and professional corporation alleging malpractice in... READ MORE

August 2022

Julie M. Janeway Honored as MLW’s “Influential Women of Law,” 2022

Foley, Baron, Metzger and Juip, PLLC is proud to announce that our Senior Healthcare Counsel, Julie M. Janeway, has been selected as one of Michigan Lawyers Weekly’s “Influential Women of Law” for 2022.  This distinction is awarded to women attorneys and judges for their excellent work on behalf of the... READ MORE

August 2022

FBMJ Welcomes New Attorney – Benjamin Demsky

Foley, Baron, Metzger & Juip, PLLC is pleased to welcome Benjamin Demsky as a new attorney to the Firm. Benjamin joined the firm as an Associate Attorney in July 2022 and will work in the Medical Malpractice practice area defending health care organizations and professionals.  Randall Juip, Member, made the announcement. Before... READ MORE

June 2022

FBMJ Welcomes Attorney Catherine Rodey

Foley, Baron, Metzger & Juip, PLLC is pleased to welcome Catherine Rodey as a new attorney to the Firm. She joined the firm on June 13, 2022 and will work in the Healthcare Law and Medical Malpractice practice groups. Randall Juip, Member, made the announcement. Prior to joining FBMJ, Catherine worked... READ MORE

June 2022

FBMJ Dismissal – When An Expert Is Not An Expert

Foley, Baron, Metzger & Juip attorney Brian W. Whitelaw successfully obtained the dismissal of a medical malpractice suit in Kent County Circuit Court on June 3, 2022 before the honorable Judge Mark A. Trusock.  Whitelaw defended a Certified Family Nurse Practitioner (NP) and professional corporation, on a theory that she... READ MORE

May 2022

Court Uses COVID-19 Immunity Provisions To Dismiss Med Mal Claim

Foley, Baron, Metzger & Juip attorneys secured the dismissal of a medical malpractice case in Wayne County Circuit Court on May 4, 2022, using state and federal COVID-19 immunity provisions. This is believed to be among the first successful uses of state and federal COVID-19 immunity protections since they were... READ MORE

April 2022

Kim Sveska Publishes Article for MPA Journal – “FDA Changes Direction Regarding Compounded Drugs”

FBMJ pharmacist attorney, Kim Sveska, recently published the article “FDA Changes Direction Regarding Compounded Drugs” in the Michigan Pharmacist Journal (2022 Vol. 60 Issue 2), a publication of the Michigan Pharmacists Association (MPA). The article discusses recent developments in the FDA’s push to obtain a Memorandum of Understanding (MOU) from... READ MORE